The RCVS reports that its alternative dispute resolution (ADR) trial is now nearing completion with over two-thirds of its target number of cases either resolved or in process.
The year-long trial, which began in November 2014, aims to gather the evidence needed to develop a permanent scheme which would provide a way of adjudicating on concerns raised about a veterinary surgeon that do not meet the RCVS threshold of serious professional misconduct.
The aim of the trial, which is administered by the independent, not-for-profit Ombudsman Services, is to make determinations on around 100 cases in order to gather information about types of concern, time taken to resolve disputes, recommendations and how likely each party is to accept recommendations. As of this week some 72 cases have been referred to the trial scheme, with final decisions made in relation to 54 of these cases.
RCVS CEO Nick Stace was responsible for pushing forward the trial believing that “what is good for the consumer is good for the profession”. The College also says it brings it into line with a European Union Directive on alternative dispute resolution which, while not legally binding, specifies that regulators and other ‘competent authorities’ should have consumer redress systems in place.
Nick said: “The majority of cases are either being determined in the veterinary surgeon’s favour or finding that they need take no further action in order to resolve the dispute. Where recommendations have been made in favour of the client, the suggested remedies have generally been for a small goodwill payment to be made.
“However, the trial has not been without some frustrations so far. The fact that participation in the trial is entirely voluntary has meant that, in many cases, members of the profession have chosen not to take part.
“With this in mind, it is very important to stress the benefits of the trial to the profession – chiefly that many of the vets who chose to take part have had their actions exonerated by Ombudsman Services in a way that a concern being closed by our Professional Conduct Department does not. For clients, where a vet does have a case to answer, it gives them the chance to seek recompense without having to resort to legal action.
“Regardless of which way the decision goes in any of these cases, participating in the trial can bring these often long-standing and burdensome disputes to a close.”
The trial will continue to run until the end of October and a full report and recommendations will be presented to RCVS Council at its meeting on Thursday 5 November 2015. Full details of the trial and its parameters can be found at www.rcvs.org.uk/adr
Bayer Animal Health has announced changes to the product indications for Baytril 50mg/ml and 100mg/ml Solutions for Injection, which both contain enrofloxacin.
Baytril 50mg/ml and 100mg/ml Solutions for Injection, now have licensed indications for the treatment of sheep and goats.
Baytril 50mg/ml and 100mg/ml* Solutions for Injection are now licensed for the treatment of acute mycoplasma-associated arthritis due to enrofloxacin- susceptible strains of Mycoplasma bovis in cattle (*in cattle less than 2 years old.)
For the treatment of acute severe mastitis caused by enrofloxacin - susceptible strains ofEscherichia coli in cattle, the second injection of Baytril 100 mg/ml Solution for Injection may now be given subcutaneously, 24 hours after the first dose administered by intravenous injection. In this case, the withdrawal period following subcutaneous injection should be applied.
For more information, refer to the product data sheets at www.noahcompendium.co.uk and SPCs or speak to your local Bayer Animal Health representative.
Scientists from the Animal Health Trust, the Wellcome Trust Sanger Institute and the University of St. Andrews have pinpointed the genes which allow the bacteria responsible for strangles to thrive, thereby paving the way for the development of a vaccine.
In the study, which the researchers say was the largest of its kind, 224 samples of Streptococcus equi (S. equi) were procured from horses around the globe to try and find a common bacterial ancestor from which modern strains would have developed. Despite the disease first being described in 1251, the researchers were surprised at the genetic similarity of the samples and identified a total population replacement at the 19th or early 20th century. This corresponds to a period when horses from around the world were brought together in global conflicts including World War I, where an estimated eight million horses died on the battlefield.
Dr Simon Harris from the Wellcome Trust Sanger Institute said: “The mobilisation and mixing of horses in conflicts such as WWI provided perfect conditions for S. equi to thrive. This combined with high mortality rates among the horses and their replacement with young susceptible horses could explain what we see around the world today".
While loss of diversity could be considered detrimental to bacterial populations, S. equi still infects more than 20,000 horses in the UK alone each year. Its success, researchers believe, is due to its ability to persist in some horses for years after they have recovered from strangles, where the bug can evolve to evade the horse’s immune system.
Dr Andrew Waller, Head of Bacteriology at the Animal Health Trust said: “The data we have gathered in this study has enabled us to pinpoint the genes that help the bacteria to persist, spread and thrive in the horse population. This research provides an unprecedented opportunity to reduce the impact of and prevent strangles in future generations of horses.”
The AHT says that the ability of S. equi to adapt to living in a persistent state within its host and still infect new horses mirrors the situation with HIV and the bacteria that causes tuberculosis in humans. Dr Matthew Holden from the Wellcome Trust Sanger Institute and the University of St Andrews said: “Unravelling the complex population dynamics of S. equi sheds new light on the balancing act between acute and persistent infection that is going on in many pathogens. Not only does this collection of whole-genome sequences for S. equi offer hope for an effective strangles vaccine, it also provides us with a useful model for understanding persistent infection in humans.”
Lincolnshire veterinary surgeon David Bull MRCVS has won a Vet Futures ‘Headlines of tomorrow’ competition with his entry: ‘Vets and medics collaborate to prevent human and animal obesity’.
The competition was held at BSAVA Congress in April where Vet Futures-themed fortune cookies contained a message asking those attending ‘What future headline do you want to see?’ and providing a weblink to enter the competition.
David, a joint partner at Vets4Pets in Lincoln South and an Advanced Practitioner in General Small Animal Surgery, said: "The headline was inspired by topical issues, having ‘One Health’ in mind and the issue of obesity in our patients, as well as the general human population. I feel that these are some of the big issues of our time, especially that of obesity which has been linked to so many other diseases and is essentially a self-induced problem.
“We see so many overweight cats, dogs and rabbits on a daily basis. It seems to be becoming a more common problem, as well as seemingly more accepted in society. This is to the extent that we have some clients that come in worried because they have been told that their dog is too thin, when in actual fact they are in an ideal body condition and are being compared to overweight pets which have become perceived as normal.”
Some of the other topics raised in the competition include the veterinary profession taking the lead in tackling ‘superbugs’, veterinary surgeons topping job satisfaction and wellbeing polls and the profession taking a leading role in One Health and medical advancements.
Ceva Animal Health has launched Libeo, a new four-way break, palatable furosemide for the management of heart failure in dogs.
According to the company, furosemide - a diuretic - is the most frequently used treatment for the management of heart failure because it helps reduce pulmonary oedema and its quick onset of action is associated with a noticeable reduction in clinical signs.
However, Ceva highlights the fact that long-term under or over-dosing can have profound health implications for the patient, and says that current recommendations are to reduce the dose to the minimum effective dose as soon as the animal is stable and only increase it if required due to deterioration in heart function.
Ceva says that unlike other furosemides, Libeo has been designed solely for the veterinary market - specifically to facilitate easy and accurate dosing.
The four-way break tablet is available in a traditional 40mg tablet size as well as a unique 10mg size for small patients. The clover-shaped tablet is chicken-flavoured, designed to make it easier for owners to dose their pets and help improve long-term owner compliance. Each box of Libeo contains 120 blister-packed tablets, removing the need for someone to have to count out tablets.
Rob McLintock MRCVS, Companion Animal Business Unit Manager at Ceva Animal Health said: “87% of vets in the UK believe that the dose of furosemide given to pets by their owners is adversely affected by how difficult it is to split the tablets1. This is especially likely to affect pets whose owners are less dextrous or have difficulties using their hands. Libeo is both easy to administer and effective, thereby improving owner compliance and the long term health and welfare of their pets.”
Reference
Virbac has launched Neoprinil, an eprinomectin pour-on solution indicated for use against internal and external parasites in cattle, including gut and lungworms, mange mites, sucking and chewing lice, horn flies and warbles.
Neoprinil has a zero-day withdrawal period in milk and can be administered using the company's Farmpack and Flexibag.
The Farmpack is a backpack which holds a Flexibag of Neoprinil solution. The Flexibag is a bag designed to protect medication and preserve it once it has been opened. The two together were awarded the 2014 PharmaPack Award for Innovative Packaging.
Neoprinil offers a one year stability period once it has first been opened and requires no special conditions for storage. It is presented in 2.5L, 4.5l and 8l pack sizes.
Product Manager for Large Animals Brigitte Goasduf MRCVS said: "A high worm burden can have adverse effects on the herd's productivity and performance and so it is advisable to ensure infected animals are treated as part of a Herd Health Plan. Eprinomectin is a tried and trusted parasiticide and studies confirm that it can have a positive impact on both milk production and on weight gain. Its zero day withdrawal period is a major benefit for dairy farmers.
"With the launch first of Deltanil and, now, Neoprinil, we are reinforcing our commitment to work with veterinary surgeons and farmers to understand the everyday challenges they face and to provide practical, effective solutions. We offer a comprehensive parasiticide range with a dispensing system that sets a new standard for convenience and ease of use."
The RCVS has published a new video which explains the Professional Development Phase (PDP) and highlights the support it provides for new veterinary graduates as they develop their Year One Competences.
In the video, Victoria Henry MRCVS - who works at Mandeville Veterinary Hospital in Northolt - speaks about how the PDP has helped her move from being a newly-qualified graduate to becoming a confident practitioner. She said: “It’s a massive transition coming out of vet school and going into practice – you suddenly have all the responsibility and it’s all on you. The PDP gives you goalposts to work towards and flags up the areas you don’t have much practice in; it helps you to reflect on what you’ve been doing and assess yourself.”
Jeremy Stewart, the Head Veterinary Surgeon at Mandeville Veterinary Hospital, talks about how the PDP helps employers to support and develop graduates like Victoria by building their confidence and helping them gain the experience they need for practice life.
The video also highlights the support available for graduates undertaking the PDP and features Julian Wells, one of the five Postgraduate Deans who help graduates undertaking the PDP by providing advice on any issues they may encounter, checking their progress and confirming when they have completed it. He also describes how the PDP helps graduates to understand the mentoring role in practice, which they can then provide to new graduates as they progress through their own careers.
Christine Warman, Head of Education at the RCVS, said: “With 859 new UK graduates having just joined the Register, we thought this video would be helpful in setting out why the PDP can be so crucial in helping to build the confidence and experience of new graduates, as well as the fact that it can easily be incorporated into day-to-day work.”
More information about the PDP is available by visiting www.rcvs.org.uk/pdp or by emailing pdp@rcvs.org.uk.
Veterinary surgeons who wish to sign up to the Professional Development Record can do so by visiting www.rcvs-pdr.org.uk
Researchers at the Animal Health Trust are appealing for information from veterinary surgeons who have seen recent Eosinophilic Keratitis (EK) conditions, an emerging issue in UK equine ophthalmology.
The AHT says that despite the increased awareness of EK worldwide, the aetiopathogenesis of the disease remains poorly understood and probably underdiagnosed. The charity is looking to define the pathogenesis and determine why some horses are particularly susceptible to this condition, in particular looking for epidemiological links, environmental factors and parasitic infestation.
Many of the clinical signs of EK are non-specific and similar to other corneal conditions such as blepharospasm, chemosis, conjunctival hyperaemia, epiphora or perilesional oedema. More specific signs include caseous mucoid discharge and white/yellow plaques often localised in the peripheral cornea. The degree of pain varies and concurrent ulceration is almost always present. Conjunctivitis may also occur in association with the keratitis or as a unique disease entity.
EK can have variable clinical presentations, from a thick caseous accumulation to a more superficial plaque of “ground-glass” appearance. They may present as chronic non-healing ulcers that respond quickly to the use of topical steroids and/or ciclosporin, or present with marked ocular discomfort and require superficial keratectomy to resolve the condition.
Two different corneal locations are classically (though not exclusively) involved in EK, the medial perilimbal cornea, often under the third eyelid, or the lateral perilimbal cornea, which may progress axially towards the central cornea.
The charity is also providing free cytology tests for corneal scrapes to help vets diagnose EK earlier, thereby avoiding secondary complications that can lead to permanent visionary impairment.
If you have seen cases that have either been diagnosed as or that you suspect to be Eosinophilic Keratitis this year, contact Sonia Gonzalez-Medina on 01638 751000 Ext: 1203 or sonia.gonzalez-medina@aht.org.uk.
For more information and to download a copy of the submission form to accompany samples, visit www.aht.org.uk/EKstudy.
The RCVS is encouraging veterinary surgeons, veterinary nurses and other members of the practice team to respond to a government consultation on changing the law to introduce English language testing for veterinary surgeons who have qualified from elsewhere in the European Union.
Under the proposals outlined in the consultation by the Department for Environment, Food and Rural Affairs (Defra), the test would apply before an individual joined the Register and only where the RCVS had ‘serious and concrete doubts’ about their English language abilities. The plan to consult on this issue had been welcomed by RCVS Council at its June 2015 meeting.
Every year, around half of all new veterinary surgeon registrants are from outside the UK, the majority from other EU or European Economic Area (EEA) countries. These individuals fall within the scope of the Mutual Recognition of Professional Qualifications (MRPQ) Directive, which applies to all EU nationals wishing to practise in a regulated profession in another member state.
Last year, a revised version of the MRPQ Directive came into force, which made a number of changes, including clarifying and reinforcing the role of competent authorities such as the RCVS. One of these changes is that language testing is expressly permitted, but only where serious concerns have been identified.
Gordon Hockey, RCVS Registrar, said: “Under the current legislation the College is not able to bar someone from joining the Register, and therefore practising, on the basis of language ability, even where we may have serious concerns.
“I would encourage all veterinary surgeons, veterinary nurses and other members of the practice team to engage with this consultation and consider whether the College should have the right to impose a language test where it has serious doubts, more in line with medical doctors, and the form such testing would take.”
Under the proposals, applicants would be asked a series of questions concerning their language qualifications, experience and general ability to use the English language before registering. Depending on how they answer the questions they may then have to pass a language test before registering, or delay their application while they improve their language skills.
The consultation results will inform the College’s work with Defra to determine whether to proceed with implementation and, if so, to develop the most appropriate system of language testing. The College would implement language testing for veterinary nurses in parallel with any changes for veterinary surgeons.
Those who wish to take part in the consultation can do so at https://consult.defra.gov.uk/animal-health-and-welfare/vet_language_controls. The deadline for responses is Wednesday 30 September 2015.
CVS has announced that it is to support the Small Animal Veterinary Surveillance Network (SAVSNET), a charity initiative run jointly by the BSAVA and the University of Liverpool to monitor health and illness in companion animals using anonymised data from veterinary practices and laboratories.
The group will be linking its practices, of which there are now more than 290, to SAVSNET through their practice management systems in a rollout that will continue until the end of the year.
Through its research and analysis, SAVSNET aims to monitor disease trends over time; identify populations at risk and monitor treatments and outcomes. It also aims to provide data and improve public awareness of small animal diseases and prevention. One of its projects delivers near-real-time (within 24 hours) practice-based syndromic surveillance based on data received from participating veterinary surgeons, who through a single mouse click, record information at the end of each consultation through their practice management system. The data is automatically sent to SAVSNET for secure storage and analysis. The whole process is designed to avoid any impact on a practices already busy work flow.
Dr Alan Radford, one of SAVSNET’s principal investigators, said: "Reusing electronic health data has a massive potential to improve animal and human health. SAVSNET is one project leading the way in this research and it is great to be working with CVS, with its scale and also its focus on high quality veterinary care.
"Working together, SAVSNET and members of the CVS team can really help understand in a new way the diseases seen by the populations under our care. As a small thank you for participation, practices that take part are provided with a secure on-line portal where they can see free anonymised benchmarking statistics including disease data and antibacterial use. Greater knowledge will enable us to target interventions to those animals most at risk, to identify risk factors for disease and to focus veterinary research efforts."
Marcus Evans, Head of Practice Management Systems at CVS said: "We are very impressed at the projects being carried out by the SAVSNET team and are keen to support its work, particularly as our veterinary teams can do it so quickly and easily through RoboVet, our practice management system. As a large veterinary group, and one that is continuing to grow rapidly, our support will add significant weight to SAVNET's efforts and we are delighted to be contributing to such valuable research."
The London Vet Show has announced it will be offering delegates the chance to win a £12,000 trip to Thailand with Worldwide Veterinary Service (WVS) at this year’s event (Olympia Grand, 19th & 20th November).
Delegates will be able to enter the competition by collecting a stamp in their LVS passport from each of the participating sponsors’ stands in the exhibition.
The 13-day working holiday kicks off by flying to Chang Mai in Thailand via Bangkok. The winners will then travel to the Narittaya Resort and Spa where they'll be staying in a private villa with its own pool. Working over the next six days with the WVS team in Chang Mai, they will be supporting an ongoing neutering and vaccination campaign while also training local vets in best practice surgical techniques.
The winners will get the opportunity to explore the temples in the ancient city of Chang Mai and a highlight of the trip will be an overnight visit to the Elephant Nature Park, which is dedicated to providing care and assistance to Thailand’s captive elephant population. The overnight stay will include a full orientation of the park and the elephants and a chance to bathe and swim with the herd in the river and communicate with them.
The winners will also have a chance to go either white water rafting or bamboo rafting.
For further information on the London Vet Show or to register to attend the event visit londonvetshow.co.uk.
Virbac has launched Nutribound, a complementary feed to help stimulate eating and drinking in inappetent cats and dogs.
The company says the product has been designed to help animals recovering from surgery or illness and those that are just experiencing a general lack of interest in food or water.
Nutribound is given alongside the pet’s diet but can also be given by tube or syringe if needed.
Claire Lewis, Product Manager, said: "Pets that lose interest in their food can be challenging for owners to deal with - and a pet that is struggling to eat or drink what it needs, especially after illness or surgery is more likely to have a prolonged recovery.
"Nutribound's palatable formulation aims to 'jump-start' normal eating behaviour by stimulating the animal's appetite and increasing its interest in eating and drinking again.
"Nutribound is presented in a handy-sized, take-home bottle and is easy for pet owners to administer. It can be given for up to 14 days or until a return to normal eating and drinking behaviour is observed. We are delighted to add it to our nutritional support range, alongside Nutri-Plus gel, our high energy, nutritional supplement for cats and dogs."
Merial has announced the launch of NexGard Spectra, a broad spectrum oral parasiticide for dogs.
NexGard Spectra contains afoxolaner, which kills fleas and ticks on dogs, and milbemycin oxime, which is effective against roundworms, hookworms and whipworms.
The new product is delivered in a beef flavoured chew to help compliance.
NexGard Spectrum is available in five different weight ranges to suit puppies and dogs of all sizes.
Dr Bradley Viner has been invested as the President of the RCVS for 2015/16 at a ceremony held at the Institution of Civil Engineers in Westminster.
Bradley has been an elected member of RCVS Council since 2005 and was Treasurer from 2010 to 2014. During his time on Council he served on a number of committees including both Education and Standards as well as chairing the Certificate in Advanced Veterinary Practice Subcommittee and the now obsolete Planning and Resources Committee.
Having graduating from the Royal Veterinary College in 1978, Bradley established a small animal practice in outer north-west London in 1979 which has now expanded to a group of five practices. Bradley was also among one of the first veterinary surgeons in the UK to achieve a higher award in veterinary general practice upon obtaining an MSc (VetGP) with Middlesex University.
Bradley is well known for his media work, writing for publications such as The Veterinary Times and Your Cat as well as broadcasting, with regular stints as the ‘in-house’ vet for programmes such as The Big Breakfast, Blue Peter and This Morning. He is also a Trustee of Battersea Dogs and Cats Home and Chair of its Building Committee as well as being Vice-President of International Cat Care.
Bradley highlighted three areas that he considered crucial for his presidential year:
He said: “If I had to pick a theme for my year it would be continual improvement. It is a very easy term to bandy about, but much more difficult to actually implement it efficiently. It involves accepting that there are many different ways we can tackle the challenges we face, and that we rarely do things perfectly. It is only by recognising our imperfections that we can get better, and it takes courage to open oneself up to criticism.
“I think back to my somewhat chequered school reports, which I had to sheepishly take home to my father, and the rather frequent comments that “Bradley could do better”. I think they meant it as criticism, but I would now take it as positive encouragement. The College is doing extremely well. It can continue to improve and become even better. During my year I undertake to do everything in my ability to ensure that it does.”
Upon receiving the chain of office from the outgoing President Professor Stuart Reid, Bradley’s first official duty was to welcome the new Junior Vice-President Chris Tufnell saying that he was an ideal person to take on the role and praising his “calm but authoritative manner, and his passion for educational matters from the perspective of a practising vet.”
Bradley praised the outgoing President Professor Stuart Reid as a “hard act to follow” – particularly in light of him running this year’s London Marathon. Professor Reid then took up the position of Senior Vice-President, replacing Colonel Neil Smith.
Research published online in the Veterinary Record has revealed that one in four dogs competing in Crufts is overweight, despite the perception that entrants are supposed to represent ideal specimens of their breed1.
The researchers based their findings on 1120 online images of dogs from 28 breeds —- half of which are prone to obesity — that had appeared at Crufts, the largest dog show of its kind in the world.
Only adult dogs that had been placed between first and fifth in their class between 2001 and 2013 were included in the study.
The images were coded and anonymised, and 960 were deemed suitable for assessment. A second person then graded the body condition of each dog in one sitting, using a previously validated method. One in four (252; 26%) was found to be overweight.
Pugs, basset hounds, and Labrador retrievers were the breeds most likely to be assessed as being overweight. Dogs were overweight in 80% of the pug images, 68% of the Basset Hound and 63% of the Labrador images.
The researchers said that the three breeds with the highest prevalence of being overweight among the online images are prone to excess weight. Nevertheless, since pugs were originally bred to be a companion dog, while hounds and Labradors were bred for hunting and fieldwork respectively, being overweight would not be advantageous.
Standard poodles, border terriers, Rhodesian ridgebacks, Hungarian vizlas and Dobermanns were the least likely breeds to be overweight.
The prevalence of being overweight among the show dogs was less than that reported generally for pet dogs in the UK. Nevertheless, the researchers say the fact that a quarter were above ideal weight is still a cause for concern: “These dogs showcase the ideal characteristics of the pedigree breed, and there is a danger that widespread media exposure might adversely influence owner perception of optimal body shape.”
The Kennel Club has recently introduced changes in policy for judging criteria, to emphasise characteristics that promote good health in dogs. However, the researchers say that breed standards of optimal condition should be reinforced for competition, to ensure consistency: “Further effort is now required to educate owners, breeders and show judges so that they can all better recognise overweight condition, thus helping to prevent the development of obesity.”
Best in show but not best in shape: a photographic assessment of show dog body condition doi 10.1136/vr.103093
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
Dechra Veterinary Products has launched a 5 ml bottle of Comfortan (methadone), its titratable analgesia for cats and dogs.
The new sized bottle of Comfortan, designed for use with animals in, or about to experience, moderate to severe pain, is now available from veterinary wholesalers.
Dechra Brand Manager Craig Sankey said: “The new 5ml bottle is a great size for practices which would like to introduce Comfortan into their practice protocols, allowing them to do so in a cost-effective way.
“The availability of a smaller bottle will also be a benefit to practices which due to different surgical needs, currently only use Comfortan in a small number of cases. They will then be able to simply and easily trade up to the 10 ml bottle once they start to use Comfortan on more cases.”
The 5 ml has also been introduced in response to demand from branch practices which had been transferring 10ml bottles between sites and for cat-focused practices which use smaller volumes of the product.
Teeside veterinary nurses Debbie Rowley and Karen Taylor from Wilton Vets made history yesterday when they were called out to catch a 6ft, 18lb python spotted by the side of the road by a motorist in Guisborough.
Talking to the Guisborough Gazette, Debbie said: "We were shocked it was so big."
The snake is apparently in good shape, and now in the care of Kirkleatham Owl Centre.
Anyone missing a 6ft ft python is asked to contact Cleveland Police on 101.
The RCVS has announced the new recruits for the two independent statutory committees responsible for investigating and holding inquiries into concerns raised about the professional conduct of veterinary surgeons.
The Disciplinary Committee has seven new members (three laypeople and four veterinary surgeons) and is now chaired by Ian Green, a former magistrate and Chief Executive of YMCA England from 2008 to 2013, who has been a member of the Committee since 2013.
The new members are:
The Preliminary Investigation Committee has three new members (all of them veterinary surgeons) and is now chaired by Andrew Ash MRCVS, a director of a veterinary practice group and Past-President of the British Small Animal Veterinary Association (BSAVA), who has been a member of the Committee since 2013. The new members are:
The College says these changes now bring it into line with a Legislative Reform Order which came into effect in July 2013 and which amended the Veterinary Surgeons Act to say that the two statutory committees should be constituted separately from RCVS Council.
Gordon Hockey, RCVS Registrar, said: “We pushed forward the LRO because we wanted to make sure that the College was following regulatory best practice by ensuring the independence of those who adjudicate on concerns raised about a veterinary surgeon’s professional conduct and fitness to practise.
“The LRO allowed for a two-year transitional period and so, with these new appointments, we see it come to fruition as the committee members are now wholly separate from RCVS Council members, who are ineligible to sit on the Disciplinary or Preliminary Investigation committees.
“I would like to extend a very warm welcome to the new Chairs and members of the committees. They all went through a rigorous recruitment process over a number of months this year and I am confident in their integrity, independence, judgement and abilities.”
Through the same independent recruitment process two new members have also been appointed to the VN Preliminary Investigation Committee – Suzanne May RVN and Susan Macaldowie MRCVS.
Details of the Disciplinary and Preliminary Investigation committees can be found at www.rcvs.org.uk/about-us/committees/disciplinary-committee and www.rcvs.org.uk/about-us/committees/preliminary-investigation-committee respectively.
The London Vet Show, which takes place on Thursday 19th November and Friday 20th November at the Olympia Grand, has announced the business programme for 2015.
The programme will include:
Rob Chapman, group event director of the London Vet Show and France Vet said: "The business programme at the London Vet Show has gone from strength to strength with a plethora of informative lectures from top class industry leaders. The informative content includes hints and tips that veterinary professionals can utilise in practice to help enhance their veterinary teams, increase profits and develop their business.”
For further information on the business programme at the London Vet Show or to register for the show visit londonvetshow.co.uk/business.
Dechra Veterinary Products has launched TAF Spray (thiamphenicol), a next generation antibiotic wound spray for superficial wound infections in horses, cattle, goats, sheep and pigs.
Dechra says TAF Spray can also be used to treat infections of the claw and hoof in cattle, goats and sheep such as foot rot, interdigital dermatitis and digital dermatitis.
TAF Spray is the only licensed wound spray for horses and has a zero day meat withdrawal period for horses, cattle, goats, sheep, and 14 days for pigs.
Dechra is also highlighting the fact that TAF Spray is the only golden yellow coloured product of its kind on the market, allowing treatment areas to be distinguished clearly.
Brand Manager Emma Jennings said: “Dechra has developed TAF Spray in direct response to the research we conducted among farmers".
The research1 showed that 51% of the veterinary surgeons had used an antibiotic spray for the treatment of digital dermatitis – an infection that 92% of farmers had experienced in their livestock in the past 12 months.
Emma added: "Thiamphenicol is a highly effective antibiotic. With the brightly coloured spray format making it distinguishable from other treatments and a can that is able to be used in upright and inverted positions, we are sure that TAF Spray will become a popular product among veterinary professionals.”
TAF Spray comes in a 150ml can with a 360-degree nozzle which allows wounds to be targeted at any angle.
For further information about Dechra’s antibiotic portfolio, visit www.dechra.co.uk
Langford Veterinary Services, a fully owned subsidiary of the University of Bristol, has announced the opening of a new standing equine magnetic resonance imaging (MRI) facility at the university's equine centre.
The equine MRI facility completes the diagnostic imaging facilities in the School, which include a 16-slice CT scanner for small animals and standing horses, digital radiography, high-resolution fluoroscopy, diagnostic ultrasound, echocardiography and scintigraphy with a high-resolution 1.5 tesla MRI scanner, available seven days a week.
Evita Busschers, Senior Teaching Fellow and orthopaedic surgeon in the equine centre, said: “We are very grateful to the Trustees of the Alborada Trust and the Langford Trust who have provided generous support for the MRI facility. The new imaging facility will enable us to provide an even better and more complete service for our equine patients and completes the diagnostic imaging facilities available at the centre.
“Equine MRI offers the ability to image soft tissue structures and identify soft tissue injuries that cannot be demonstrated with other diagnostic imaging modalities and therefore has major additional value in providing a diagnosis and prognosis in lameness evaluations.”
Miles Littlewort, a trustee from the Alborada Trust added: “Donating the money is the easy bit but ensuring that it has been used where it should be and that it has made the necessary difference is much more challenging. We are so pleased to have had the opportunity to support the Langford Trust and their work to improve animal health and welfare. We are delighted to have attended the opening, to meet the clinicians who will use the magnificent facility and to learn about the clinical research which gives all veterinary surgeons evidence-based information to enhance diagnosis and treatment for all patients.”
From the start of 2016, the RCVS will no longer allow veterinary surgeons or veterinary nurses to enter undocumented continuing professional development (CPD) on their records.
Under the RCVS Codes of Professional Conduct, veterinary surgeons are required to record a minimum of 105 hours of CPD over a three-year period, while veterinary nurses are expected to carry out 45 hours of CPD over the same period.
Historically, vets and nurses have been able to record 10 and 5 hours as undocumented private study per annum respectively. The RCVS Education Committee decided to discontinue the allowance for vets in May and the Veterinary Nursing Committee followed suit in June.
Julie Dugmore, RCVS Head of Veterinary Nursing, said: “As with the veterinary surgeons, this decision was made because it was felt that all CPD, including private study, should be properly documented on the CPD records of veterinary nurses.
“This change, however, is not intended to discourage private study which we recognise extends across a range of different types of learning, including reading, and can be very valuable for personal development, but merely that it should be properly documented.”
The College says it hopes the changes will also clear up uncertainty around the respective allowances for veterinary surgeons and veterinary nurses, as some were under the impression that private study, even if it was documented, could only be classed within that category.
The Education Department is also in the process of reviewing the information available to veterinary surgeons and veterinary nurses regarding what counts as CPD, in order to clear up uncertainty and provide more specific examples for each learning category.
Information about CPD for veterinary surgeons can be found at www.rcvs.org.uk/cpd, while for veterinary nurses the information is available at www.rcvs.org.uk/vncpd
Boehringer Ingelheim has launched Care and Connect a free online PPID aftercare service for horse owners, designed to help veterinary practices monitor their PPID case load and streamline the case management process.
The new service is part of Boehringer's 'Talk About Laminitis (TAL)' Awareness campaign.
The company says that PPID is the sixth most frequently encountered disease syndrome affecting equids in the UK1, and the new service should help engage owners and vets post diagnosis, thereby maximising treatment success.
Liz Barrett, equine business manager at Boehringer, said: “PPID is a progressive disease, so it is vital that veterinary surgeons remain at the centre of care, and that horses are monitored carefully following their initial diagnosis. However we recognise the high administrative demand associated with this, and TAL Care and Connect has been designed to reduce this as much as possible.”
TAL Care and Connect will be offered automatically to horse owners who take advantage of this year’s free* ACTH testing scheme, which will be available from July to November. Equine practices can also offer this aftercare service to all owners of previously diagnosed PPID cases.
Owners who join TAL Care and Connect will be able to set up a profile for their horse which allows all their ACTH results to be stored in one place. They will then receive the relevant reminders for follow-up ACTH testing which will make it easier for vets to monitor their patient’s progress over time.
In addition, owners can download an independently-written PPID information pack. Edited by Prof. Catherine McGowan with contributions from Dr Jo Ireland, Prof. Andy Durham, David Rendle and Dr Teresa Hollands, the pack includes advice on monitoring and follow-up ACTH tests, feeding, general care of the PPID patient and the link between laminitis and PPID.
Talk About Laminitis is supported by Redwings, The British Horse Society and World Horse Welfare, and will run from July until the end of October 2015. Horse owners can find out more and obtain their free ACTH voucher code at www.talkaboutlaminitis.co.uk.
For further information contact your local Boehringer territory manager or visit www.talkaboutlaminitis.co.uk.
*Cost of laboratory test
References
Vet Futures, the joint initiative by the RCVS and the BVA to help the profession prepare for and shape its own future, has revealed the results of a survey which found that 59% of veterinary surgeons are optimistic about the future of the profession. 600 vets took part in the survey, which explored vets' attitudes towards their profession, and asked them to prioritise the key issues and rank some of the major threats and opportunities for the profession.Reducing stress was the single most important goal for the future, with 19% of respondents choosing it from a long list of options.The BVA and the RCVS say that priority goals for veterinary surgeons varied according to different areas of work and seniority in the profession. However, an overriding and uniting theme from the findings was the pursuit of recognition for the role vets play across the board. Vets' perception of the veterinary contribution to non-clinical roles, such as research, food supply and security, and public health, is high, but they don't believe the general public values these roles.Four of the respondents' top five goals for 2030 related to recognition:
Looking at how vets are respected and valued by society, Vet Futures points to its national ICM opinion poll of more than 2,000 members of the public which found that 94% of the general public trusts the veterinary profession generally or completely.
In terms of their own careers, 59% of vets said they felt that they had met or exceeded their expectations, leaving 41% saying their careers had only met some expectations (38%) or not met any (3%). Amongst this large minority of dissatisfied vets the reasons for their responses included: few opportunities for progression, pay, and working hours.The survey also asked vets to rank threats and opportunities for the profession and found that respondents considered the three greatest opportunities to be:
BVA President John Blackwell said: "It's heartening to see that, at the moment, the veterinary glass is half full for many. But we know that younger vets are disproportionately represented amongst those who are feeling less positive about their own careers, which is a real concern for future generations. There is clearly work to be done, through Vet Futures, for the profession to think innovatively in order to tackle some of their concerns around career progression, pay and working hours, as well as stress."The good news is that, through the Vet Futures UK-wide roadshow and our online engagement, we have been hearing new and interesting ideas for the future. We want to hear from as many vets, vet nurses and others who have a stake in the future of the profession and I would encourage people to get involved through our 'Veterinary Vision' essay competition or via the Vet Futures website."RCVS President Stuart Reid added: "There is a lot for the veterinary profession to be proud of but the Vet Futures survey shows that vets are concerned the general public doesn't understand or value the variety of roles we undertake outside clinical practice."We have also heard through our guest blog that vets working outside of practice sometimes feel that they are treated as second-class vets. "Through the Vet Futures project RCVS and BVA aim to address the lack of public awareness about the variety of roles undertaken by members of the profession, as well as increase understanding and access to these varied career opportunities amongst the profession. "We want to enable all veterinary surgeons to not only feel optimistic, but confident in their future."